Latest Articles

Publication Date
All News Scientific
Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer - OncLive

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer OncLive

Published: April 24, 2024, 7 a.m.
Read Full Article
GSK's endometrial cancer drug receives FDA approval - ShareCast

GSK's endometrial cancer drug receives FDA approval ShareCast

Published: April 24, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire

Published: April 24, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting Investor Relations | Karyopharm Therapeutics

Published: April 24, 2024, 7 a.m.
Read Full Article
Novel ADC and Immunotherapy Combo Shows Promise for Endometrial Cancer - Cancer Health Treatment News

Novel ADC and Immunotherapy Combo Shows Promise for Endometrial Cancer Cancer Health Treatment News

Published: April 9, 2024, 7 a.m.
Read Full Article
Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer - OncLive

Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer OncLive

Published: April 8, 2024, 7 a.m.
Read Full Article
Pennington Biomedical: Raising awareness of endometrial cancer - Greater Baton Rouge Business Report

Pennington Biomedical: Raising awareness of endometrial cancer Greater Baton Rouge Business Report

Published: April 8, 2024, 7 a.m.
Read Full Article
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer - Li - 2024 - Advanced Science - Wiley Online Library

Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer - Li - 2024 - Advanced Science Wiley Online Library

Published: April 6, 2024, 7 a.m.
Read Full Article
Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer - OncLive

Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer OncLive

Published: April 2, 2024, 7 a.m.
Read Full Article
Rubraca sheds positive light for PARP inhibitors in endometrial cancer - Clinical Trials Arena

Rubraca sheds positive light for PARP inhibitors in endometrial cancer Clinical Trials Arena

Published: April 2, 2024, 7 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!